Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sonia Moretti

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Frontiers in Immunology|April 27, 2026
Therapeutic HIV-1 Tat vaccination promotes durable immune reconstitution and reservoir reduction in ART-treated adults with clade C infection: a 12-year follow-up studyOrietta Picconi, Cecilia Sgadari, Antonella Tripiciano, et al.
Plos One|October 31, 2014
Biocompatible anionic polymeric microspheres as priming delivery system for effetive HIV/AIDS Tat-based vaccinesFausto Titti, Maria T Maggiorella, Flavia Ferrantelli, et al.
Frontiers in Immunology|March 1, 2019
Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up StudyCecilia Sgadari, Paolo Monini, Antonella Tripiciano, et al.
Ebiomedicine|April 11, 2021
Anti-Tat immunity defines CD4<sup>+</sup> T-cell dynamics in people living with HIV on long-term cARTAntonella Tripiciano, Orietta Picconi, Sonia Moretti, et al.
Retrovirology|June 10, 2016
HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trialBarbara Ensoli, Maphoshane Nchabeleng, Fabrizio Ensoli, et al.
Vaccine|August 17, 2004
Long-term protection against SHIV89.6P replication in HIV-1 Tat vaccinated cynomolgus monkeysMaria Teresa Maggiorella, Silvia Baroncelli, Zuleika Michelini, et al.
Human Mutation|February 12, 2009
Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: molecular diversity and associated phenotypic spectrumAnna Sarkozy, Claudio Carta, Sonia Moretti, et al.
DNA and Cell Biology|October 25, 2002
HIV-1 Tat-based vaccines: from basic science to clinical trialsEmanuele Fanales-Belasio, Aurelio Cafaro, Andrea Cara, et al.
Retrovirology|May 1, 2015
HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trialFabrizio Ensoli, Aurelio Cafaro, Anna Casabianca, et al.
Plos One|November 16, 2012
HIV-1 tat promotes integrin-mediated HIV transmission to dendritic cells by binding Env spikes and competes neutralization by anti-HIV antibodiesPaolo Monini, Aurelio Cafaro, Indresh K Srivastava, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Frontiers in Immunology|April 27, 2026
Therapeutic HIV-1 Tat vaccination promotes durable immune reconstitution and reservoir reduction in ART-treated adults with clade C infection: a 12-year follow-up studyOrietta Picconi, Cecilia Sgadari, Antonella Tripiciano, et al.
Plos One|October 31, 2014
Biocompatible anionic polymeric microspheres as priming delivery system for effetive HIV/AIDS Tat-based vaccinesFausto Titti, Maria T Maggiorella, Flavia Ferrantelli, et al.
Frontiers in Immunology|March 1, 2019
Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up StudyCecilia Sgadari, Paolo Monini, Antonella Tripiciano, et al.
Ebiomedicine|April 11, 2021
Anti-Tat immunity defines CD4<sup>+</sup> T-cell dynamics in people living with HIV on long-term cARTAntonella Tripiciano, Orietta Picconi, Sonia Moretti, et al.
Retrovirology|June 10, 2016
HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trialBarbara Ensoli, Maphoshane Nchabeleng, Fabrizio Ensoli, et al.
Vaccine|August 17, 2004
Long-term protection against SHIV89.6P replication in HIV-1 Tat vaccinated cynomolgus monkeysMaria Teresa Maggiorella, Silvia Baroncelli, Zuleika Michelini, et al.
Human Mutation|February 12, 2009
Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: molecular diversity and associated phenotypic spectrumAnna Sarkozy, Claudio Carta, Sonia Moretti, et al.
DNA and Cell Biology|October 25, 2002
HIV-1 Tat-based vaccines: from basic science to clinical trialsEmanuele Fanales-Belasio, Aurelio Cafaro, Andrea Cara, et al.
Retrovirology|May 1, 2015
HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trialFabrizio Ensoli, Aurelio Cafaro, Anna Casabianca, et al.
Plos One|November 16, 2012
HIV-1 tat promotes integrin-mediated HIV transmission to dendritic cells by binding Env spikes and competes neutralization by anti-HIV antibodiesPaolo Monini, Aurelio Cafaro, Indresh K Srivastava, et al.
Pageof 7